Males and females aged 20 to 64 years old
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Males and females aged 20 to 64 years old (2) Subjects whose fasting blood glucose levels are 125 mg/dL or under in the preliminary check. (3) Subjects whose HbA1c levels are 6.4% or under. (4) Subjects who can give informed consent to participate in this study, after being provided with an explanation of the protocol detail.
Exclusion criteria
Exclusion criteria: (1) Subjects who are having Food for Specified Health Uses (FOSHU), Foods with functional claims and/or health food, including supplements, (including suppression of blood glucose level elevation, etc.) which might affect this study, three times or more a week. (2)Subjects who are taking medications (e.g., diabetes medications) that may affect this study. (3) Subjects who are participating, participated within the last four weeks before this study, or are planning to participate another clinical study of medication or health food. (4) Subjects who have extremely disheveled dietary habits. (5) Subjects who have disheveled lifestyle (e.g., shift workers and night workers). (6) Heavy drinkers (7) Subjects with abnormal thyroid function in the preliminary check. (8) Subjects who have been diagnosed as anemia or have subjective symptoms of anemia. (9) Subjects who have past and present medical history of serious diseases of heart, liver, kidney, digestive organs, and/or thyroid gland, etc. (10) Pregnant women, lactating women, or women who want to get pregnant during this study. (11) Subjects who are allergic to drugs or food. (12) Subjects who have donated over 200 mL of whole blood and/or blood components within the last one month prior to this study. (13) Male subjects who have donated over 400 mL of whole blood within the last three months prior to this study. (14) Female subjects who have donated over 400 mL of whole blood within the last four months prior to this study. (15) Male subjects whose total volume of the blood drawn within the last 12 months and this study exceed 1200 mL (16) Female subjects whose total volume of the blood drawn within the last 12 months and this study exceed 1200 mL (17) Subjects who have been determined ineligible by principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| glucose | — |
Secondary
| Measure | Time frame |
|---|---|
| Insulin Glucagon GLP-1 GIP | — |
Countries
Japan
Contacts
Meiji Co., Ltd. Food Microbiology and Function Research Laboratories, R&D Division